| Year |
Citation |
Score |
| 2020 |
Chey WD, Shah ED, DuPont HL. Mechanism of action and therapeutic benefit of rifaximin in patients with irritable bowel syndrome: a narrative review. Therapeutic Advances in Gastroenterology. 13: 1756284819897531. PMID 32047534 DOI: 10.1177/1756284819897531 |
0.335 |
|
| 2020 |
DuPont HL, Jiang ZD, DuPont AW, Utay NS. Abnormal Intestinal Microbiome in Medical Disorders and Potential Reversibility by Fecal Microbiota Transplantation. Digestive Diseases and Sciences. PMID 32008133 DOI: 10.1007/S10620-020-06102-Y |
0.326 |
|
| 2020 |
Ali H, Ma W, Khurana S, Jiang Z, DuPont HL, Okhuysen P, Thomas A, Wang Y. Safety and efficacy of fecal microbiota transplantation (FMT) in the management of recurrent clostridioides difficile infection (rCDI) in cancer patients. Journal of Clinical Oncology. 38: e24048-e24048. DOI: 10.1200/Jco.2020.38.15_Suppl.E24048 |
0.321 |
|
| 2020 |
Wang Y, Ma W, Abu-Sbeih H, Jiang Z, DuPont HL. Fecal microbiota transplantation (FMT) for immune checkpoint inhibitor induced–colitis (IMC) refractory to immunosuppressive therapy. Journal of Clinical Oncology. 38: 3067-3067. DOI: 10.1200/Jco.2020.38.15_Suppl.3067 |
0.31 |
|
| 2018 |
Bamidele O, Jiang ZD, Dupont H. Occurrence of putative virulence-related genes, aatA, aggR and aaiC, of Enteroaggregative Escherichia coli (EAEC) among adults with travelers' diarrhea acquired in Guatemala and Mexico. Microbial Pathogenesis. 128: 97-99. PMID 30579944 DOI: 10.1016/J.Micpath.2018.12.030 |
0.304 |
|
| 2018 |
Lindsay L, DuPont HL, Moe CL, Alberer M, Hatz C, Kirby AE, Wu HM, Verstraeten T, Steffen R. Estimating the incidence of norovirus acute gastroenteritis among US and European international travelers to areas of moderate to high risk of traveler's diarrhea: a prospective cohort study protocol. Bmc Infectious Diseases. 18: 605. PMID 30509202 DOI: 10.1186/S12879-018-3461-6 |
0.317 |
|
| 2018 |
Steffen R, Jiang ZD, Gracias Garcia ML, Araujo P, Stiess M, Nacak T, Greinwald R, DuPont HL. Rifamycin SV-MMX® for treatment of travelers' diarrhea: equally effective as ciprofloxacin and not associated with the acquisition of multi-drug resistant bacteria. Journal of Travel Medicine. PMID 30462260 DOI: 10.1093/Jtm/Tay116 |
0.334 |
|
| 2018 |
Zhu Q, Dupont CL, Jones MB, Pham KM, Jiang ZD, DuPont HL, Highlander SK. Visualization-assisted binning of metagenome assemblies reveals potential new pathogenic profiles in idiopathic travelers' diarrhea. Microbiome. 6: 201. PMID 30409177 DOI: 10.1186/S40168-018-0579-0 |
0.341 |
|
| 2018 |
Jiang ZD, Jenq RR, Ajami NJ, Petrosino JF, Alexander AA, Ke S, Iqbal T, DuPont AW, Muldrew K, Shi Y, Peterson C, Do KA, DuPont HL. Safety and preliminary efficacy of orally administered lyophilized fecal microbiota product compared with frozen product given by enema for recurrent Clostridium difficile infection: A randomized clinical trial. Plos One. 13: e0205064. PMID 30388112 DOI: 10.1371/Journal.Pone.0205064 |
0.324 |
|
| 2018 |
Dogan B, Belcher-Timme HF, Dogan EI, Jiang ZD, DuPont HL, Synder N, Yang S, Chandler B, Scherl EJ, Simpson KW. Evaluation of Escherichia coli pathotypes associated with Irritable Bowel Syndrome. Fems Microbiology Letters. PMID 30299475 DOI: 10.1093/Femsle/Fny249 |
0.32 |
|
| 2018 |
Valilis E, Ramsey A, Sidiq S, DuPont HL. Non-O157 Shiga Toxin-Producing Escherichia coli - a Poorly Appreciated Enteric Pathogen: Systematic Review. International Journal of Infectious Diseases : Ijid : Official Publication of the International Society For Infectious Diseases. PMID 30223088 DOI: 10.1016/J.Ijid.2018.09.002 |
0.323 |
|
| 2018 |
Oyaro MO, Plants-Paris K, Bishoff D, Malonza P, Gontier CS, DuPont HL, Darkoh C. High Rate of Clostridium difficile Among Young Adults Presenting with Diarrhea to Two Hospitals in Kenya. International Journal of Infectious Diseases : Ijid : Official Publication of the International Society For Infectious Diseases. PMID 29960098 DOI: 10.1016/J.Ijid.2018.06.014 |
0.335 |
|
| 2018 |
Bajaj JS, Barbara G, DuPont HL, Mearin F, Gasbarrini A, Tack J. New concepts on intestinal microbiota and the role of the non-absorbable antibiotics with special reference to rifaximin in digestive diseases. Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association For the Study of the Liver. PMID 29807873 DOI: 10.1016/J.Dld.2018.04.020 |
0.305 |
|
| 2018 |
Jiang Z, Jenq R, Ajami N, DuPont HL. Tu1019 - The Effect of type of Inoculum and Administration Route of Fecal Microbiotatransplantation in Subjects with Recurrent Clostridium Difficile Infection (CDI) Gastroenterology. 154: S-892. DOI: 10.1016/S0016-5085(18)33011-7 |
0.305 |
|
| 2018 |
Plumb PK, Dubberke ER, Orenstein R, Khanna S, Hecht GA, DuPont HL, Lee C, Gerding DN. 1013 - The Microbiota-Based Drug Rbx2660 is Efficacious and Safe in Patients with Recurrent Clostridium Difficile Infections: Results from 2 Controlled Clinical Trials Gastroenterology. 154: S-192. DOI: 10.1016/S0016-5085(18)31045-X |
0.318 |
|
| 2017 |
Chao AW, Bhatti M, DuPont HL, Nataro JP, Carlin LG, Okhuysen PC. Clinical features and molecular epidemiology of diarrheagenic Escherichia coli pathotypes identified by fecal gastrointestinal multiplex nucleic acid amplification in patients with cancer and diarrhea. Diagnostic Microbiology and Infectious Disease. PMID 28931467 DOI: 10.1016/J.Diagmicrobio.2017.08.004 |
0.369 |
|
| 2017 |
Darkoh C, Deaton M, DuPont HL. Nonantimicrobial drug targets for Clostridium difficile infections. Future Microbiology. PMID 28759258 DOI: 10.2217/Fmb-2017-0024 |
0.372 |
|
| 2017 |
Jiang ZD, DuPont HL. Etiology of travellers' diarrhea. Journal of Travel Medicine. 24: S13-S16. PMID 28521001 DOI: 10.1093/Jtm/Tax003 |
0.363 |
|
| 2017 |
Jiang ZD, Ajami NJ, Petrosino JF, Jun G, Hanis CL, Shah M, Hochman L, Ankoma-Sey V, DuPont AW, Wong MC, Alexander A, Ke S, DuPont HL. Randomised clinical trial: faecal microbiota transplantation for recurrent Clostridum difficile infection - fresh, or frozen, or lyophilised microbiota from a small pool of healthy donors delivered by colonoscopy. Alimentary Pharmacology & Therapeutics. PMID 28220514 DOI: 10.1111/Apt.13969 |
0.307 |
|
| 2017 |
Kharat VB, Ahmed M, Jiang ZD, Riddle MS, DuPont HL. Colonization Factors in Enterotoxigenic Escherichia coli Strains in Travelers to Mexico, Guatemala, and India Compared with Children in Houston, Texas. The American Journal of Tropical Medicine and Hygiene. 96: 83-87. PMID 28077742 DOI: 10.4269/Ajtmh.16-0405 |
0.719 |
|
| 2016 |
Nicholson MR, Crews JD, Starke JR, Jiang ZD, DuPont H, Edwards K. Recurrent Clostridium difficile Infection in Children: Patient Risk Factors and Markers of Intestinal Inflammation. The Pediatric Infectious Disease Journal. PMID 27977555 DOI: 10.1097/Inf.0000000000001450 |
0.308 |
|
| 2016 |
DuPont HL, Wolf RA, Israel RJ, Pimentel M. Antimicrobial Susceptibility of Skin Isolates of Staphylococcus From Patients With Diarrhea-Predominant Irritable Bowel Syndrome Treated With Repeat Courses of Rifaximin. Antimicrobial Agents and Chemotherapy. PMID 27795384 DOI: 10.1128/Aac.02165-16 |
0.308 |
|
| 2016 |
Darkoh C, Odo C, DuPont HL. Accessory Gene Regulator-1 Locus Is Essential for Virulence and Pathogenesis of Clostridium difficile. Mbio. 7. PMID 27531912 DOI: 10.1128/Mbio.01237-16 |
0.34 |
|
| 2016 |
Shah DN, Aitken SL, Barragan LF, Bozorgui S, Goddu S, Navarro ME, Xie Y, DuPont HL, Garey KW. Economic burden of primary compared with recurrent Clostridium difficile infection in hospitalized patients: a prospective cohort study. The Journal of Hospital Infection. PMID 27209056 DOI: 10.1016/J.Jhin.2016.04.004 |
0.318 |
|
| 2016 |
Riddle MS, DuPont HL, Connor BA. ACG Clinical Guideline: Diagnosis, Treatment, and Prevention of Acute Diarrheal Infections in Adults. The American Journal of Gastroenterology. PMID 27068718 DOI: 10.1038/Ajg.2016.126 |
0.343 |
|
| 2016 |
Dupont HL. Rifaximin: An antibiotic with important biologic effects Mini-Reviews in Medicinal Chemistry. 16: 200-205. DOI: 10.2174/1389557515666150722110201 |
0.337 |
|
| 2016 |
Jiang Z, Garey K, Lasco T, Dupont H. Fecal Calprotectin as a Biomarker for Clostridium Difficile Infection: 141 The American Journal of Gastroenterology. 111. DOI: 10.14309/00000434-201610001-00141 |
0.304 |
|
| 2016 |
Dupont HL. Review article: The antimicrobial effects of rifaximin on the gut microbiota Alimentary Pharmacology and Therapeutics. 43: 3-10. DOI: 10.1111/Apt.13434 |
0.342 |
|
| 2016 |
Dupont HL. Introduction: Understanding mechanisms of the actions of rifaximin in selected gastrointestinal diseases Alimentary Pharmacology and Therapeutics. 43: 1-2. DOI: 10.1111/Apt.13406 |
0.311 |
|
| 2016 |
Hanania A, Jiang ZD, Smiley C, Lasco T, Garey KW, DuPont HL. Fecal calprotectin in the diagnosis of clostridium difficile infection Infectious Diseases in Clinical Practice. 24: 31-34. DOI: 10.1097/Ipc.0000000000000312 |
0.301 |
|
| 2016 |
Kharat V, Ahmed M, Jiang Z, Dupont H. Colonization Factors in Enterotoxigenic Escherichia coli (ETEC) Isolates From Travelers to Mexico, Guatemala and India Compared With Children in Houston, Texas: Evidence of the Importance of CS21 Open Forum Infectious Diseases. 3. DOI: 10.1093/Ofid/Ofw172.907 |
0.715 |
|
| 2015 |
Patel R, DuPont HL. New approaches for bacteriotherapy: prebiotics, new-generation probiotics, and synbiotics. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 60: S108-21. PMID 25922396 DOI: 10.1093/Cid/Civ177 |
0.33 |
|
| 2015 |
Darkoh C, DuPont HL, Norris SJ, Kaplan HB. Toxin synthesis by Clostridium difficile is regulated through quorum signaling. Mbio. 6: e02569. PMID 25714717 DOI: 10.1128/Mbio.02569-14 |
0.343 |
|
| 2015 |
Chertow DS, Uyeki TM, DuPont HL. Loperamide therapy for voluminous diarrhea in Ebola virus disease. The Journal of Infectious Diseases. 211: 1036-7. PMID 25573887 DOI: 10.1093/Infdis/Jiv001 |
0.352 |
|
| 2014 |
Crews JD, Koo HL, Jiang ZD, Starke JR, DuPont HL. A hospital-based study of the clinical characteristics of Clostridium difficile infection in children. The Pediatric Infectious Disease Journal. 33: 924-8. PMID 25361022 DOI: 10.1097/Inf.0000000000000338 |
0.306 |
|
| 2014 |
Aitken SL, Joseph TB, Shah DN, Lasco TM, Palmer HR, DuPont HL, Xie Y, Garey KW. Healthcare resource utilization for recurrent Clostridium difficile infection in a large university hospital in Houston, Texas. Plos One. 9: e102848. PMID 25057871 DOI: 10.1371/Journal.Pone.0102848 |
0.304 |
|
| 2014 |
DuPont HL. Challenges and opportunities in the management of Clostridium difficile infection. Expert Review of Gastroenterology & Hepatology. 8: 863-74. PMID 25012255 DOI: 10.1586/17474124.2014.939630 |
0.354 |
|
| 2014 |
Dupont HL. Review article: Evidence for the role of gut microbiota in irritable bowel syndrome and its potential influence on therapeutic targets Alimentary Pharmacology and Therapeutics. 39: 1033-1042. PMID 24665829 DOI: 10.1111/Apt.12728 |
0.302 |
|
| 2014 |
Nair P, Okhuysen PC, Jiang ZD, Carlin LG, Belkind-Gerson J, Flores J, Paredes M, DuPont HL. Persistent abdominal symptoms in US adults after short-term stay in Mexico. Journal of Travel Medicine. 21: 153-8. PMID 24621006 DOI: 10.1111/Jtm.12114 |
0.548 |
|
| 2014 |
Ajami NJ, Kavanagh OV, Ramani S, Crawford SE, Atmar RL, Jiang ZD, Okhuysen PC, Estes MK, DuPont HL. Seroepidemiology of norovirus-associated travelers' diarrhea. Journal of Travel Medicine. 21: 6-11. PMID 24383649 DOI: 10.1111/Jtm.12092 |
0.32 |
|
| 2013 |
Darkoh C, Brown EL, Kaplan HB, DuPont HL. Bile salt inhibition of host cell damage by Clostridium difficile toxins. Plos One. 8: e79631. PMID 24244530 DOI: 10.1371/Journal.Pone.0079631 |
0.318 |
|
| 2013 |
Dupont HL. Chronic complications after travelers' diarrhea. Journal of Travel Medicine. 20: 273-4. PMID 23992567 DOI: 10.1111/Jtm.12045 |
0.345 |
|
| 2013 |
Han XH, Du CX, Zhang CL, Zheng CL, Wang L, Li D, Feng Y, DuPont HL, Jiang ZD, Shi YK. Clostridium difficile infection in hospitalized cancer patients in Beijing, China is facilitated by receipt of cancer chemotherapy Anaerobe. 24: 82-84. PMID 23770543 DOI: 10.1016/J.Anaerobe.2013.05.004 |
0.31 |
|
| 2013 |
DuPont HL. Giardia: both a harmless commensal and a devastating pathogen. The Journal of Clinical Investigation. 123: 2352-4. PMID 23728170 DOI: 10.1172/Jci69932 |
0.313 |
|
| 2013 |
Huang JS, Jiang ZD, Garey KW, Lasco T, Dupont HL. Use of rifamycin drugs and development of infection by rifamycin-resistant strains of Clostridium difficile. Antimicrobial Agents and Chemotherapy. 57: 2690-3. PMID 23545528 DOI: 10.1128/Aac.00548-13 |
0.333 |
|
| 2013 |
Dupont HL. Diagnosis and management of Clostridium difficile infection. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. 11: 1216-23; quiz e73. PMID 23542332 DOI: 10.1016/J.Cgh.2013.03.016 |
0.374 |
|
| 2013 |
Kothary V, Scherl EJ, Bosworth B, Jiang ZD, Dupont HL, Harel J, Simpson KW, Dogan B. Rifaximin resistance in Escherichia coli associated with inflammatory bowel disease correlates with prior rifaximin use, mutations in rpoB, and activity of Phe-Arg-β-naphthylamide-inhibitable efflux pumps. Antimicrobial Agents and Chemotherapy. 57: 811-7. PMID 23183443 DOI: 10.1128/Aac.02163-12 |
0.323 |
|
| 2013 |
Dogan B, Scherl E, Bosworth B, Yantiss R, Altier C, McDonough PL, Jiang ZD, Dupont HL, Garneau P, Harel J, Rishniw M, Simpson KW. Multidrug resistance is common in Escherichia coli associated with ileal Crohn's disease. Inflammatory Bowel Diseases. 19: 141-50. PMID 22508665 DOI: 10.1002/Ibd.22971 |
0.314 |
|
| 2013 |
Crews JD, Koo H, Starke J, DuPont HL. Sa1227 Characteristics of Pediatric Clostridium difficile Infection Gastroenterology. 144: S-235. DOI: 10.1016/S0016-5085(13)60833-1 |
0.314 |
|
| 2012 |
Boyce JM, Dupont HL, Massaro J, Sack D, Schaffner DW. An expert panel report of a proposed scientific model demonstrating the effectiveness of antibacterial handwash products. American Journal of Infection Control. 40: 742-9. PMID 22300895 DOI: 10.1016/J.Ajic.2011.09.016 |
0.303 |
|
| 2012 |
Pfeiffer ML, DuPont HL, Ochoa TJ. The patient presenting with acute dysentery--a systematic review. The Journal of Infection. 64: 374-86. PMID 22266388 DOI: 10.1016/J.Jinf.2012.01.006 |
0.302 |
|
| 2012 |
DuPont HL. Approach to the patient with infectious colitis. Current Opinion in Gastroenterology. 28: 39-46. PMID 22080825 DOI: 10.1097/Mog.0B013E32834D3208 |
0.343 |
|
| 2011 |
Bavishi C, DuPont HL. Systematic review: The use of proton pump inhibitors and increased susceptibility to enteric infection Alimentary Pharmacology and Therapeutics. 34: 1269-1281. PMID 21999643 DOI: 10.1111/J.1365-2036.2011.04874.X |
0.353 |
|
| 2011 |
Garey KW, Ghantoji SS, Shah DN, Habib M, Arora V, Jiang ZD, DuPont HL. A randomized, double-blind, placebo-controlled pilot study to assess the ability of rifaximin to prevent recurrent diarrhoea in patients with Clostridium difficile infection. The Journal of Antimicrobial Chemotherapy. 66: 2850-5. PMID 21948965 DOI: 10.1093/Jac/Dkr377 |
0.332 |
|
| 2011 |
DuPont AW, DuPont HL. The intestinal microbiota and chronic disorders of the gut. Nature Reviews. Gastroenterology & Hepatology. 8: 523-31. PMID 21844910 DOI: 10.1038/Nrgastro.2011.133 |
0.313 |
|
| 2011 |
Flores-Figueroa J, Okhuysen PC, von Sonnenburg F, DuPont HL, Libman MD, Keystone JS, Hale DC, Burchard G, Han PV, Wilder-Smith A, Freedman DO. Patterns of illness in travelers visiting Mexico and Central America: the GeoSentinel experience. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 53: 523-31. PMID 21832261 DOI: 10.1093/Cid/Cir468 |
0.32 |
|
| 2011 |
Darkoh C, DuPont HL. Unraveling the role of host endocytic proteins in pedestal formation during enteropathogenic Escherichia coli infection. The Journal of Infectious Diseases. 204: 667-8. PMID 21810916 DOI: 10.1093/Infdis/Jir391 |
0.306 |
|
| 2011 |
Paredes-Paredes M, Flores-Figueroa J, Dupont HL. Advances in the treatment of travelers' diarrhea. Current Gastroenterology Reports. 13: 402-7. PMID 21773708 DOI: 10.1007/S11894-011-0208-6 |
0.322 |
|
| 2011 |
Arora V, Kachroo S, Ghantoji SS, Dupont HL, Garey KW. High Horn's index score predicts poor outcomes in patients with Clostridium difficile infection. The Journal of Hospital Infection. 79: 23-6. PMID 21700363 DOI: 10.1016/J.Jhin.2011.04.027 |
0.577 |
|
| 2011 |
Mohamed JA, DuPont HL, Flores J, Palur H, Nair P, Jiang ZD, Guo D, Belkind-Gerson J, Okhuysen PC. Single nucleotide polymorphisms in the promoter of the gene encoding the lipopolysaccharide receptor CD14 are associated with bacterial diarrhea in US and Canadian travelers to Mexico. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 52: 1332-41. PMID 21596674 DOI: 10.1093/Cid/Cir228 |
0.542 |
|
| 2011 |
Paredes-Paredes M, Okhuysen PC, Flores J, Mohamed JA, Padda RS, Gonzalez-Estrada A, Haley CA, Carlin LG, Nair P, DuPont HL. Seasonality of diarrheagenic Escherichia coli pathotypes in the US students acquiring diarrhea in Mexico. Journal of Travel Medicine. 18: 121-5. PMID 21366796 DOI: 10.1111/J.1708-8305.2010.00488.X |
0.575 |
|
| 2011 |
DuPont HL. The search for effective treatment of Clostridium difficile infection. The New England Journal of Medicine. 364: 473-5. PMID 21288079 DOI: 10.1056/Nejme1013236 |
0.354 |
|
| 2011 |
Long KZ, Santos JI, Rosado JL, Estrada-Garcia T, Haas M, Al Mamun A, DuPont HL, Nanthakumar NN. Vitamin A supplementation modifies the association between mucosal innate and adaptive immune responses and resolution of enteric pathogen infections. The American Journal of Clinical Nutrition. 93: 578-85. PMID 21248183 DOI: 10.3945/Ajcn.110.003913 |
0.301 |
|
| 2011 |
DuPont HL. Biologic properties and clinical uses of rifaximin. Expert Opinion On Pharmacotherapy. 12: 293-302. PMID 21226639 DOI: 10.1517/14656566.2011.546347 |
0.31 |
|
| 2011 |
Villa NA, Okhuysen PC, Flores-Figueroa J, Jiang ZD, Belkind-Gerson J, Paredes M, Mohamed JA, Nair P, Carlin L, DuPont HL. Campylobacter jejuni is not an important pathogen as a cause of diarrhea in US travelers to Mexico. Journal of Travel Medicine. 18: 56-8. PMID 21199144 DOI: 10.1111/J.1708-8305.2010.00469.X |
0.586 |
|
| 2011 |
Ouyang-Latimer J, Jafri S, VanTassel A, Jiang ZD, Gurleen K, Rodriguez S, Nandy RK, Ramamurthy T, Chatterjee S, McKenzie R, Steffen R, DuPont HL. In vitro antimicrobial susceptibility of bacterial enteropathogens isolated from international travelers to Mexico, Guatemala, and India from 2006 to 2008. Antimicrobial Agents and Chemotherapy. 55: 874-8. PMID 21115800 DOI: 10.1128/Aac.00739-10 |
0.345 |
|
| 2010 |
Dupont HL, Garey KW. Clostridium difficile infection: an emerging epidemic with more questions than answers. Future Microbiology. 5: 1153-6. PMID 20722592 DOI: 10.2217/Fmb.10.80 |
0.311 |
|
| 2010 |
Okhuysen PC, Dupont HL. Enteroaggregative Escherichia coli (EAEC): a cause of acute and persistent diarrhea of worldwide importance. The Journal of Infectious Diseases. 202: 503-5. PMID 20594108 DOI: 10.1086/654895 |
0.326 |
|
| 2010 |
Cottreau J, Baker SF, DuPont HL, Garey KW. Rifaximin: a nonsystemic rifamycin antibiotic for gastrointestinal infections. Expert Review of Anti-Infective Therapy. 8: 747-60. PMID 20586560 DOI: 10.1586/Eri.10.58 |
0.383 |
|
| 2010 |
Darkoh C, Lichtenberger LM, Ajami N, Dial EJ, Jiang ZD, DuPont HL. Bile acids improve the antimicrobial effect of rifaximin. Antimicrobial Agents and Chemotherapy. 54: 3618-24. PMID 20547807 DOI: 10.1128/Aac.00161-10 |
0.333 |
|
| 2010 |
Ajami N, Koo H, Darkoh C, Atmar RL, Okhuysen PC, Jiang ZD, Flores J, DuPont HL. Characterization of norovirus-associated traveler's diarrhea Clinical Infectious Diseases. 51: 123-130. PMID 20540620 DOI: 10.1086/653530 |
0.302 |
|
| 2010 |
Koo HL, Garey KW, Dupont HL. Future novel therapeutic agents for Clostridium difficile infection. Expert Opinion On Investigational Drugs. 19: 825-36. PMID 20521993 DOI: 10.1517/13543784.2010.495386 |
0.344 |
|
| 2010 |
Shah D, Dang MD, Hasbun R, Koo HL, Jiang ZD, DuPont HL, Garey KW. Clostridium difficile infection: update on emerging antibiotic treatment options and antibiotic resistance. Expert Review of Anti-Infective Therapy. 8: 555-64. PMID 20455684 DOI: 10.1586/Eri.10.28 |
0.357 |
|
| 2010 |
Martinez-Sandoval F, Ericsson CD, Jiang ZD, Okhuysen PC, Romero JH, Hernandez N, Forbes WP, Shaw A, Bortey E, DuPont HL. Prevention of travelers' diarrhea with rifaximin in US travelers to Mexico. Journal of Travel Medicine. 17: 111-7. PMID 20412178 DOI: 10.1111/J.1708-8305.2009.00385.X |
0.341 |
|
| 2010 |
Koo HL, Ajami NJ, Jiang ZD, Neill FH, Atmar RL, Ericsson CD, Okhuysen PC, Taylor DN, Bourgeois AL, Steffen R, DuPont HL. Noroviruses as a cause of diarrhea in travelers to Guatemala, India, and Mexico. Journal of Clinical Microbiology. 48: 1673-6. PMID 20305012 DOI: 10.1128/Jcm.02072-09 |
0.379 |
|
| 2010 |
DuPont HL, Galler G, Garcia-Torres F, Dupont AW, Greisinger A, Jiang ZD. Travel and travelers' diarrhea in patients with irritable bowel syndrome. The American Journal of Tropical Medicine and Hygiene. 82: 301-5. PMID 20134008 DOI: 10.4269/Ajtmh.2010.09-0538 |
0.31 |
|
| 2010 |
Jiang ZD, Ke S, Dupont HL. Rifaximin-induced alteration of virulence of diarrhoea-producing Escherichia coli and Shigella sonnei. International Journal of Antimicrobial Agents. 35: 278-81. PMID 20045287 DOI: 10.1016/J.Ijantimicag.2009.11.013 |
0.303 |
|
| 2010 |
Vigil KJ, Johnson JR, Johnston BD, Kontoyiannis DP, Mulanovich VE, Raad II, Dupont HL, Adachi JA. Escherichia coli Pyomyositis: an emerging infectious disease among patients with hematologic malignancies. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 50: 374-80. PMID 20038242 DOI: 10.1086/649866 |
0.362 |
|
| 2009 |
Koo HL, Dupont HL, Huang DB. The role of rifaximin in the treatment and chemoprophylaxis of travelers' diarrhea. Therapeutics and Clinical Risk Management. 5: 841-8. PMID 19898648 DOI: 10.2147/Tcrm.S4442 |
0.365 |
|
| 2009 |
Yadav Y, Garey KW, Dao-Tran TK, Kaila V, Gbito KYE, DuPont HL. Automated system to identify Clostridium difficile infection among hospitalised patients Journal of Hospital Infection. 72: 337-341. PMID 19596490 DOI: 10.1016/J.Jhin.2009.04.017 |
0.302 |
|
| 2009 |
Chongsuvivatwong V, Chariyalertsak S, McNeil E, Aiyarak S, Hutamai S, Dupont HL, Jiang ZD, Kalambaheti T, Tonyong W, Thitiphuree S, Steffen R. Epidemiology of travelers' diarrhea in Thailand. Journal of Travel Medicine. 16: 179-85. PMID 19538578 DOI: 10.1111/J.1708-8305.2009.00331.X |
0.328 |
|
| 2009 |
DuPont HL, Ericsson CD, Farthing MJ, Gorbach S, Pickering LK, Rombo L, Steffen R, Weinke T. Expert review of the evidence base for self-therapy of travelers' diarrhea. Journal of Travel Medicine. 16: 161-71. PMID 19538576 DOI: 10.1111/J.1708-8305.2009.00300.X |
0.343 |
|
| 2009 |
Dupont HL. Systematic review: The epidemiology and clinical features of travellers' diarrhoea Alimentary Pharmacology and Therapeutics. 30: 187-196. PMID 19392866 DOI: 10.1111/J.1365-2036.2009.04028.X |
0.346 |
|
| 2009 |
Koo HL, Ajami NJ, Jiang ZD, Atmar RL, DuPont HL. Norovirus infection as a cause of sporadic healthcare-associated diarrhoea. The Journal of Hospital Infection. 72: 185-7. PMID 19380178 DOI: 10.1016/J.Jhin.2009.03.010 |
0.394 |
|
| 2009 |
Shah N, DuPont HL, Ramsey DJ. Global etiology of travelers' diarrhea: systematic review from 1973 to the present. The American Journal of Tropical Medicine and Hygiene. 80: 609-14. PMID 19346386 DOI: 10.4269/Ajtmh.2009.80.609 |
0.33 |
|
| 2009 |
Vigil KJ, Jiang ZD, Chen JJ, Palumbo KL, Galbadage T, Brown EL, Yiang J, Koo H, DuPont MW, Ericsson C, Adachi JA, DuPont HL. Coliform and Escherichia coli contamination of desserts served in public restaurants from Guadalajara, Mexico, and Houston, Texas. The American Journal of Tropical Medicine and Hygiene. 80: 606-8. PMID 19346385 DOI: 10.4269/Ajtmh.2009.80.606 |
0.31 |
|
| 2009 |
Koo HL, Ajami NJ, Jiang ZD, Dupont HL, Atmar RL, Lewis D, Byers P, Abraham P, Quijano RA, Musher DM, Young EJ. A nosocomial outbreak of norovirus infection masquerading as clostridium difficile infection. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 48: e75-7. PMID 19245344 DOI: 10.1086/597299 |
0.337 |
|
| 2009 |
Koo HL, Koo DC, Musher DM, DuPont HL. Antimotility agents for the treatment of Clostridium difficile diarrhea and colitis. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 48: 598-605. PMID 19191646 DOI: 10.1086/596711 |
0.325 |
|
| 2009 |
Galbadage T, Jiang ZD, DuPont HL. Improvement in detection of enterotoxigenic Escherichia coli in patients with travelers' diarrhea by increasing the number of E. coli colonies tested. The American Journal of Tropical Medicine and Hygiene. 80: 20-3. PMID 19141833 DOI: 10.4269/Ajtmh.2009.80.20 |
0.308 |
|
| 2009 |
Estrada-Garcia T, Lopez-Saucedo C, Thompson-Bonilla R, Abonce M, Lopez-Hernandez D, Santos JI, Rosado JL, DuPont HL, Long KZ. Association of diarrheagenic Escherichia coli Pathotypes with infection and diarrhea among Mexican children and association of atypical Enteropathogenic E. coli with acute diarrhea. Journal of Clinical Microbiology. 47: 93-8. PMID 19020055 DOI: 10.1128/Jcm.01166-08 |
0.368 |
|
| 2009 |
Dogan B, Scherl EJ, Bosworth BP, McDonough PL, Jiang Z, DuPont H, Bruant G, Harel J, Simpson KW. W1641 Escherichia coli Associated with Crohn's Disease Frequently Manifest Resistance to Commonly Recommended Antibiotics Gastroenterology. 136: A-708. DOI: 10.1016/S0016-5085(09)63265-0 |
0.313 |
|
| 2008 |
Meraz IM, Jiang ZD, Ericsson CD, Bourgeois AL, Steffen R, Taylor DN, Hernandez N, DuPont HL. Enterotoxigenic Escherichia coli and diffusely adherent E. coli as likely causes of a proportion of pathogen-negative travelers' diarrhea--a PCR-based study. Journal of Travel Medicine. 15: 412-8. PMID 19090795 DOI: 10.1111/J.1708-8305.2008.00249.X |
0.341 |
|
| 2008 |
Garey KW, Sethi S, Yadav Y, DuPont HL. Meta-analysis to assess risk factors for recurrent Clostridium difficile infection. The Journal of Hospital Infection. 70: 298-304. PMID 18951661 DOI: 10.1016/J.Jhin.2008.08.012 |
0.302 |
|
| 2008 |
Nair P, Mohamed JA, DuPont HL, Figueroa JF, Carlin LG, Jiang ZD, Belkind-Gerson J, Martinez-Sandoval FG, Okhuysen PC. Epidemiology of cryptosporidiosis in North American travelers to Mexico. The American Journal of Tropical Medicine and Hygiene. 79: 210-4. PMID 18689626 DOI: 10.4269/Ajtmh.2008.79.210 |
0.565 |
|
| 2008 |
Garey KW, Jiang ZD, Yadav Y, Mullins B, Wong K, Dupont HL. Peripartum Clostridium difficile infection: case series and review of the literature. American Journal of Obstetrics and Gynecology. 199: 332-7. PMID 18639213 DOI: 10.1016/J.Ajog.2008.05.001 |
0.348 |
|
| 2008 |
Flores J, DuPont HL, Jiang ZD, Belkind-Gerson J, Mohamed JA, Carlin LG, Padda RS, Paredes M, Martinez-Sandoval JF, Villa NA, Okhuysen PC. Enterotoxigenic Escherichia coli heat-labile toxin seroconversion in US travelers to Mexico. Journal of Travel Medicine. 15: 156-61. PMID 18494692 DOI: 10.1111/J.1708-8305.2008.00187.X |
0.341 |
|
| 2008 |
Shen BO, Jiang ZD, Fazio VW, Remzi FH, Rodriguez L, Bennett AE, Lopez R, Queener E, Dupont HL. Clostridium difficile infection in patients with ileal pouch-anal anastomosis. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. 6: 782-8. PMID 18467184 DOI: 10.1016/J.Cgh.2008.02.021 |
0.348 |
|
| 2008 |
Garey KW, Salazar M, Shah D, Rodrigue R, DuPont HL. Rifamycin antibiotics for treatment of Clostridium difficile-associated diarrhea. The Annals of Pharmacotherapy. 42: 827-35. PMID 18430792 DOI: 10.1345/Aph.1K675 |
0.302 |
|
| 2008 |
Marcos LA, Terashima A, Dupont HL, Gotuzzo E. Strongyloides hyperinfection syndrome: an emerging global infectious disease. Transactions of the Royal Society of Tropical Medicine and Hygiene. 102: 314-8. PMID 18321548 DOI: 10.1016/J.Trstmh.2008.01.020 |
0.341 |
|
| 2008 |
DuPont HL. Systematic review: Prevention of travellers' diarrhoea Alimentary Pharmacology and Therapeutics. 27: 741-751. PMID 18284650 DOI: 10.1111/J.1365-2036.2008.03647.X |
0.314 |
|
| 2007 |
DuPont HL. The growing threat of foodborne bacterial enteropathogens of animal origin Clinical Infectious Diseases. 45: 1353-1361. PMID 17968835 DOI: 10.1086/522662 |
0.31 |
|
| 2007 |
Long KZ, Rosado JL, Montoya Y, de Lourdes Solano M, Hertzmark E, DuPont HL, Santos JI. Effect of vitamin A and zinc supplementation on gastrointestinal parasitic infections among Mexican children. Pediatrics. 120: e846-55. PMID 17908741 DOI: 10.1542/Peds.2006-2187 |
0.302 |
|
| 2007 |
Huang DB, Mohamed JA, Nataro JP, DuPont HL, Jiang ZD, Okhuysen PC. Virulence characteristics and the molecular epidemiology of enteroaggregative Escherichia coli isolates from travellers to developing countries. Journal of Medical Microbiology. 56: 1386-92. PMID 17893178 DOI: 10.1099/Jmm.0.47161-0 |
0.315 |
|
| 2007 |
Ericsson CD, DuPont HL, Okhuysen PC, Jiang ZD, DuPont MW. Loperamide plus azithromycin more effectively treats travelers' diarrhea in Mexico than azithromycin alone. Journal of Travel Medicine. 14: 312-9. PMID 17883462 DOI: 10.1111/J.1708-8305.2007.00144.X |
0.304 |
|
| 2007 |
Marcos LA, DuPont HL. Advances in defining etiology and new therapeutic approaches in acute diarrhea Journal of Infection. 55: 385-393. PMID 17825422 DOI: 10.1016/J.Jinf.2007.07.016 |
0.383 |
|
| 2007 |
Long KZ, Garcia C, Santos JI, Rosado JL, Hertzmark E, Dupont HL, Ko G. Vitamin A supplementation has divergent effects on norovirus infections and clinical symptoms among Mexican children. The Journal of Infectious Diseases. 196: 978-85. PMID 17763317 DOI: 10.1086/521195 |
0.303 |
|
| 2007 |
DuPont HL. Therapy for and prevention of traveler's diarrhea Clinical Infectious Diseases. 45. PMID 17582576 DOI: 10.1086/518155 |
0.357 |
|
| 2007 |
Dupont HL, Jiang ZD, Belkind-Gerson J, Okhuysen PC, Ericsson CD, Ke S, Huang DB, Dupont MW, Adachi JA, De La Cabada FJ, Taylor DN, Jaini S, Martinez Sandoval F. Treatment of travelers' diarrhea: randomized trial comparing rifaximin, rifaximin plus loperamide, and loperamide alone. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. 5: 451-6. PMID 17382603 DOI: 10.1016/J.Cgh.2007.02.004 |
0.318 |
|
| 2007 |
McMahan ZH, DuPont HL. Review article: The history of acute infectious diarrhoea management - From poorly focused empiricism to fluid therapy and modern pharmacotherapy Alimentary Pharmacology and Therapeutics. 25: 759-769. PMID 17373914 DOI: 10.1111/J.1365-2036.2007.03261.X |
0.312 |
|
| 2007 |
Mohamed JA, DuPont HL, Jiang ZD, Belkind-Gerson J, Figueroa JF, Armitige LY, Tsai A, Nair P, Martinez-Sandoval FJ, Guo DC, Hayes P, Okhuysen PC. A novel single-nucleotide polymorphism in the lactoferrin gene is associated with susceptibility to diarrhea in North American travelers to Mexico. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 44: 945-52. PMID 17342646 DOI: 10.1086/512199 |
0.569 |
|
| 2007 |
Long KZ, Rosado JL, DuPont HL, Hertzmark E, Santos JI. Supplementation with vitamin A reduces watery diarrhoea and respiratory infections in Mexican children. The British Journal of Nutrition. 97: 337-43. PMID 17298703 DOI: 10.1017/S0007114507257757 |
0.314 |
|
| 2007 |
DuPont HL, Haake R, Taylor DN, Ericsson CD, Jiang ZD, Okhuysen PC, Steffen R. Rifaximin treatment of pathogen-negative travelers' diarrhea. Journal of Travel Medicine. 14: 16-9. PMID 17241249 DOI: 10.1111/J.1708-8305.2006.00084.X |
0.319 |
|
| 2007 |
DuPont HL. Azithromycin for the self-treatment of traveler's diarrhea Clinical Infectious Diseases. 44: 347-349. PMID 17205439 DOI: 10.1086/510594 |
0.313 |
|
| 2007 |
Mohamed JA, Huang DB, Jiang ZD, DuPont HL, Nataro JP, Belkind-Gerson J, Okhuysen PC. Association of putative enteroaggregative Escherichia coli virulence genes and biofilm production in isolates from travelers to developing countries. Journal of Clinical Microbiology. 45: 121-6. PMID 17093030 DOI: 10.1128/Jcm.01128-06 |
0.327 |
|
| 2007 |
Garcia C, Samalvides F, Dupont HL, Vidal M, Gotuzzo E. Epidemiology of Clostridium difficile–Associated Diarrhea in a Peruvian Tertiary Care Hospital The American Journal of Tropical Medicine and Hygiene. 77: 802-805. DOI: 10.4269/Ajtmh.2007.77.802 |
0.314 |
|
| 2006 |
Turner SM, Chaudhuri RR, Jiang ZD, DuPont H, Gyles C, Penn CW, Pallen MJ, Henderson IR. Phylogenetic comparisons reveal multiple acquisitions of the toxin genes by enterotoxigenic Escherichia coli strains of different evolutionary lineages. Journal of Clinical Microbiology. 44: 4528-36. PMID 17050815 DOI: 10.1128/Jcm.01474-06 |
0.332 |
|
| 2006 |
Long KZ, Santos JI, Rosado JL, Lopez-Saucedo C, Thompson-Bonilla R, Abonce M, DuPont HL, Hertzmark E, Estrada-Garcia T. Impact of vitamin A on selected gastrointestinal pathogen infections and associated diarrheal episodes among children in Mexico City, Mexico. The Journal of Infectious Diseases. 194: 1217-25. PMID 17041847 DOI: 10.1086/508292 |
0.312 |
|
| 2006 |
Huang DB, Mohanty A, DuPont HL, Okhuysen PC, Chiang T. A review of an emerging enteric pathogen: enteroaggregative Escherichia coli. Journal of Medical Microbiology. 55: 1303-11. PMID 17005776 DOI: 10.1099/Jmm.0.46674-0 |
0.39 |
|
| 2006 |
García C, DuPont HL, Long KZ, Santos JI, Ko G. Asymptomatic norovirus infection in Mexican children. Journal of Clinical Microbiology. 44: 2997-3000. PMID 16891526 DOI: 10.1128/Jcm.00065-06 |
0.311 |
|
| 2006 |
Huang DB, Nataro JP, DuPont HL, Kamat PP, Mhatre AD, Okhuysen PC, Chiang T. Enteroaggregative Escherichia coli is a cause of acute diarrheal illness: a meta-analysis. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 43: 556-63. PMID 16886146 DOI: 10.1086/505869 |
0.308 |
|
| 2006 |
DuPont HL. New Insights and Directions in Travelers' Diarrhea Gastroenterology Clinics of North America. 35: 337-353. PMID 16880069 DOI: 10.1016/J.Gtc.2006.03.008 |
0.34 |
|
| 2006 |
Koo HL, DuPont HL. Current and future developments in travelers' diarrhea therapy Expert Review of Anti-Infective Therapy. 4: 417-427. PMID 16771619 DOI: 10.1586/14787210.4.3.417 |
0.341 |
|
| 2006 |
Pacheco-Gil L, Ochoa TJ, Flores-Romo L, DuPont HL, Estrada-Garcia T. Enteroinvasive Escherichia coli severe dysentery complicated by rotavirus gastroenteritis. The Journal of Infection. 53: e211-3. PMID 16769121 DOI: 10.1016/J.Jinf.2006.01.021 |
0.343 |
|
| 2006 |
Ko G, Jiang ZD, Okhuysen PC, DuPont HL. Fecal cytokines and markers of intestinal inflammation in international travelers with diarrhea due to Noroviruses. Journal of Medical Virology. 78: 825-8. PMID 16628572 DOI: 10.1002/Jmv.20630 |
0.334 |
|
| 2006 |
Long KZ, Estrada-Garcia T, Rosado JL, Ignacio Santos J, Haas M, Firestone M, Bhagwat J, Young C, DuPont HL, Hertzmark E, Nanthakumar NN. The effect of vitamin A supplementation on the intestinal immune response in Mexican children is modified by pathogen infections and diarrhea. The Journal of Nutrition. 136: 1365-70. PMID 16614431 DOI: 10.1093/Jn/136.5.1365 |
0.302 |
|
| 2006 |
DuPont HL. Travellers' diarrhoea: Contemporary approaches to therapy and prevention Drugs. 66: 303-314. PMID 16526819 DOI: 10.2165/00003495-200666030-00003 |
0.304 |
|
| 2006 |
Adachi JA, DuPont HL. Rifaximin: A novel nonabsorbed rifamycin for gastrointestinal disorders Clinical Infectious Diseases. 42: 541-547. PMID 16421799 DOI: 10.1086/499950 |
0.327 |
|
| 2006 |
TAYLOR DN, HALPERN J, HAAKE R, BOURGEOIS AL, DUPONT HL, ERICSSON CD, STEFFEN R, JIANG Z. A RANDOMIZED, DOUBLE-BLIND, MULTICENTER STUDY OF RIFAXIMIN COMPARED WITH PLACEBO AND WITH CIPROFLOXACIN IN THE TREATMENT OF TRAVELERS’ DIARRHEA The American Journal of Tropical Medicine and Hygiene. 74: 1060-1066. DOI: 10.4269/Ajtmh.2006.74.1060 |
0.31 |
|
| 2006 |
Shen B, Jiang Z-, Fazio V, Sherman K, Rodriguez L, Remzi F, Bennett A, DuPont HL. Clostridium difficile Infection in Patients with Ileal Pouch-Anal Anastomosis (IPAA): 1081 The American Journal of Gastroenterology. 101. DOI: 10.14309/00000434-200609001-01081 |
0.316 |
|
| 2006 |
DuPont AW, DuPont HL. Traveler's diarrhea: Modern concepts and new developments Current Treatment Options in Gastroenterology. 9: 13-21. DOI: 10.1007/S11938-006-0020-9 |
0.335 |
|
| 2005 |
Ko G, Garcia C, Jiang ZD, Okhuysen PC, Belkind-Gerson J, Glass RI, DuPont HL. Noroviruses as a cause of traveler's diarrhea among students from the United States visiting Mexico. Journal of Clinical Microbiology. 43: 6126-9. PMID 16333110 DOI: 10.1128/Jcm.43.12.6126-6129.2005 |
0.339 |
|
| 2005 |
DuPont HL, Jiang ZD, Okhuysen PC, Ericsson CD, de la Cabada FJ, Ke S, DuPont MW, Martinez-Sandoval F. Antibacterial chemoprophylaxis in the prevention of traveler's diarrhea: evaluation of poorly absorbed oral rifaximin. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 41: S571-6. PMID 16267721 DOI: 10.1086/432954 |
0.307 |
|
| 2005 |
DuPont HL. Traveler's diarrhea: Antimicrobial therapy and chemoprevention Nature Clinical Practice Gastroenterology and Hepatology. 2: 191-198. PMID 16265184 DOI: 10.1038/Ncpgasthep0142 |
0.35 |
|
| 2005 |
DuPont HL. What's new in enteric infectious diseases at home and abroad Current Opinion in Infectious Diseases. 18: 407-412. PMID 16148527 DOI: 10.1097/00132980-200512000-00003 |
0.359 |
|
| 2005 |
Estrada-GarcÃa T, Cerna JF, Paheco-Gil L, Velázquez RF, Ochoa TJ, Torres J, DuPont HL. Drug-resistant diarrheogenic Escherichia coli, Mexico. Emerging Infectious Diseases. 11: 1306-8. PMID 16102327 DOI: 10.3201/Eid1108.050192 |
0.31 |
|
| 2005 |
Huang DB, DuPont HL. Problem pathogens: Extra-intestinal complications of Salmonella enterica serotype Typhi infection Lancet Infectious Diseases. 5: 341-348. PMID 15919620 DOI: 10.1016/S1473-3099(05)70138-9 |
0.362 |
|
| 2005 |
Gerard L, Garey KW, DuPont HL. Rifaximin: A nonabsorbable rifamycin antibiotic for use in nonsystemic gastrointestinal infections Expert Review of Anti-Infective Therapy. 3: 201-211. PMID 15918778 DOI: 10.1586/14787210.3.2.201 |
0.371 |
|
| 2005 |
Ericsson CD, DuPont HL. Rifaximin in the treatment of infectious diarrhea Chemotherapy. 51: 73-80. PMID 15855750 DOI: 10.1159/000081992 |
0.326 |
|
| 2005 |
Jiang ZD, Dupont HL. Rifaximin: In vitro and in vivo antibacterial activity - A review Chemotherapy. 51: 67-72. PMID 15855749 DOI: 10.1159/000081991 |
0.355 |
|
| 2005 |
Huang DB, DuPont HL. Rifaximin - A novel antimicrobial for enteric infections Journal of Infection. 50: 97-106. PMID 15667909 DOI: 10.1016/J.Jinf.2004.05.019 |
0.358 |
|
| 2004 |
DuPont HL, Jiang ZD. Influence of rifaximin treatment on the susceptibility of intestinal Gram-negative flora and enterococci Clinical Microbiology and Infection. 10: 1009-1011. PMID 15522005 DOI: 10.1111/J.1469-0691.2004.00997.X |
0.303 |
|
| 2004 |
Huang DB, Dupont HL. Enteroaggregative Escherichia coli: An emerging pathogen in children Seminars in Pediatric Infectious Diseases. 15: 266-271. PMID 15494951 DOI: 10.1053/J.Spid.2004.07.008 |
0.371 |
|
| 2004 |
Okhuysen PC, Jiang ZD, Carlin L, Forbes C, DuPont HL. Post-diarrhea chronic intestinal symptoms and irritable bowel syndrome in North American travelers to Mexico. The American Journal of Gastroenterology. 99: 1774-8. PMID 15330917 DOI: 10.1111/J.1572-0241.2004.30435.X |
0.312 |
|
| 2004 |
Huang DB, DuPont HL, Jiang ZD, Carlin L, Okhuysen PC. Interleukin-8 response in an intestinal HCT-8 cell line infected with enteroaggregative and enterotoxigenic Escherichia coli. Clinical and Diagnostic Laboratory Immunology. 11: 548-51. PMID 15138180 DOI: 10.1128/Cdli.11.3.548-551.2004 |
0.31 |
|
| 2004 |
Huang DB, Okhuysen PC, Jiang ZD, DuPont HL. Enteroaggregative Escherichia coli: an emerging enteric pathogen. The American Journal of Gastroenterology. 99: 383-9. PMID 15046233 DOI: 10.1111/J.1572-0241.2004.04041.X |
0.389 |
|
| 2004 |
Infante RM, Ericsson CD, Jiang ZD, Ke S, Steffen R, Riopel L, Sack DA, DuPont HL. Enteroaggregative Escherichia coli diarrhea in travelers: response to rifaximin therapy. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. 2: 135-8. PMID 15017618 DOI: 10.1016/S1542-3565(03)00322-7 |
0.32 |
|
| 2003 |
Adachi JA, Ericsson CD, Jiang ZD, DuPont MW, Martinez-Sandoval F, Knirsch C, DuPont HL. Azithromycin found to be comparable to levofloxacin for the treatment of US travelers with acute diarrhea acquired in Mexico. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 37: 1165-71. PMID 14557959 DOI: 10.1086/378746 |
0.315 |
|
| 2003 |
Estrada-García MT, Jiang ZD, Adachi J, Mathewson JJ, DuPont HL. Intestinal immunoglobulin a response to naturally acquired enterotoxigenic Escherichia coli in US travelers to an endemic area of Mexico. Journal of Travel Medicine. 9: 247-50. PMID 12962598 DOI: 10.2310/7060.2002.24210 |
0.309 |
|
| 2003 |
Jiang ZD, Greenberg D, Nataro JP, Steffen R, DuPont HL. Rate of occurrence and pathogenic effect of enteroaggregative Escherichia coli virulence factors in international travelers. Journal of Clinical Microbiology. 40: 4185-90. PMID 12409395 DOI: 10.1128/Jcm.40.11.4185-4190.2002 |
0.325 |
|
| 2003 |
HUANG DB, JIANG Z, DUPONT HL. ASSOCIATION OF VIRULENCE FACTOR-POSITIVE AND -NEGATIVE ENTEROAGGREGATIVE ESCHERICHIA COLI AND OCCURRENCE OF CLINICAL ILLNESS IN TRAVELERS FROM THE UNITED STATES TO MEXICO The American Journal of Tropical Medicine and Hygiene. 69: 506-508. DOI: 10.4269/Ajtmh.2003.69.506 |
0.353 |
|
| 2002 |
Bouckenooghe AR, Jiang ZD, De La Cabada FJ, Ericsson CD, DuPont HL. Enterotoxigenic Escherichia coli as cause of diarrhea among Mexican adults and US travelers in Mexico. Journal of Travel Medicine. 9: 137-40. PMID 12088579 DOI: 10.2310/7060.2002.23206 |
0.341 |
|
| 2002 |
Adachi JA, Mathewson JJ, Jiang ZD, Ericsson CD, DuPont HL. Enteric pathogens in Mexican sauces of popular restaurants in Guadalajara, Mexico, and Houston, Texas. Annals of Internal Medicine. 136: 884-7. PMID 12069562 DOI: 10.7326/0003-4819-136-12-200206180-00009 |
0.306 |
|
| 2002 |
Adachi JA, Ericsson CD, Jiang ZD, DuPont MW, Pallegar SR, DuPont HL. Natural history of enteroaggregative and enterotoxigenic Escherichia coli infection among US travelers to Guadalajara, Mexico. The Journal of Infectious Diseases. 185: 1681-3. PMID 12023779 DOI: 10.1086/340419 |
0.386 |
|
| 2002 |
Greenberg DE, Jiang ZD, Steffen R, Verenker MP, DuPont HL. Markers of inflammation in bacterial diarrhea among travelers, with a focus on enteroaggregative Escherichia coli pathogenicity. The Journal of Infectious Diseases. 185: 944-9. PMID 11920319 DOI: 10.1086/339617 |
0.305 |
|
| 2002 |
Jiang ZD, Lowe B, Verenkar MP, Ashley D, Steffen R, Tornieporth N, von Sonnenburg F, Waiyaki P, DuPont HL. Prevalence of enteric pathogens among international travelers with diarrhea acquired in Kenya (Mombasa), India (Goa), or Jamaica (Montego Bay). The Journal of Infectious Diseases. 185: 497-502. PMID 11865402 DOI: 10.1086/338834 |
0.366 |
|
| 2002 |
Huang DB, Jiang ZD, Ericsson CD, Adachi J, Dupont HL. Emergence of trimethoprim-resistant Escherichia coli in healthy persons in the absence of prophylactic or therapeutic antibiotics during travel to Guadalajara, Mexico. Scandinavian Journal of Infectious Diseases. 33: 812-4. PMID 11760159 DOI: 10.1080/00365540110076589 |
0.313 |
|
| 2001 |
Adachi JA, Jiang ZD, Mathewson JJ, Verenkar MP, Thompson S, Martinez-Sandoval F, Steffen R, Ericsson CD, DuPont HL. Enteroaggregative Escherichia coli as a major etiologic agent in traveler's diarrhea in 3 regions of the world. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 32: 1706-9. PMID 11360211 DOI: 10.1086/320756 |
0.368 |
|
| 2001 |
Bouckenooghe AR, Dupont HL, Jiang ZD, Adachi J, Mathewson JJ, Verenkar MP, Rodrigues S, Steffen R. Markers of enteric inflammation in enteroaggregative Escherichia coli diarrhea in travelers. The American Journal of Tropical Medicine and Hygiene. 62: 711-3. PMID 11304060 DOI: 10.4269/Ajtmh.2000.62.711 |
0.35 |
|
| 2001 |
Guerrant RL, Van Gilder T, Slutsker L, Tauxe RV, Hennessy T, Griffin PM, Pickering LK, Steiner TS, Thielman NM, DuPont H, Bradley Sack R, Tarr P, Neill M, Nachamkin I, Reller LB, et al. Practice guidelines for the management of infectious diarrhea Clinical Infectious Diseases. 32: 331-351. PMID 11170940 DOI: 10.1086/318514 |
0.366 |
|
| 2001 |
Gomi H, Jiang ZD, Adachi JA, Ashley D, Lowe B, Verenkar MP, Steffen R, DuPont HL. In vitro antimicrobial susceptibility testing of bacterial enteropathogens causing traveler's diarrhea in four geographic regions. Antimicrobial Agents and Chemotherapy. 45: 212-6. PMID 11120968 DOI: 10.1128/Aac.45.1.212-216.2001 |
0.348 |
|
| 2000 |
Adachi JA, Ostrosky-Zeichner L, DuPont HL, Ericsson CD. Empirical antimicrobial therapy for traveler's diarrhea. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 31: 1079-83. PMID 11049792 DOI: 10.1086/318119 |
0.364 |
|
| 2000 |
von Sonnenburg F, Tornieporth N, Waiyaki P, Lowe B, Peruski LF, DuPont HL, Mathewson JJ, Steffen R. Risk and aetiology of diarrhoea at various tourist destinations. Lancet (London, England). 356: 133-4. PMID 10963251 DOI: 10.1016/S0140-6736(00)02451-X |
0.349 |
|
| 2000 |
Dann SM, Okhuysen PC, Salameh BM, DuPont HL, Chappell CL. Fecal antibodies to Cryptosporidium parvum in healthy volunteers Infection and Immunity. 68: 5068-5074. PMID 10948127 DOI: 10.1128/Iai.68.9.5068-5074.2000 |
0.313 |
|
| 2000 |
Paredes P, Campbell-Forrester S, Mathewson JJ, Ashley D, Thompson S, Steffen R, Jiang ZD, Svennerholm AM, DuPont HL. Etiology of travelers' diarrhea on a Caribbean island. Journal of Travel Medicine. 7: 15-8. PMID 10689233 DOI: 10.2310/7060.2000.00004 |
0.309 |
|
| 2000 |
Jiang ZD, Mathewson JJ, Ericsson CD, Svennerholm AM, Pulido C, DuPont HL. Characterization of enterotoxigenic Escherichia coli strains in patients with travelers' diarrhea acquired in Guadalajara, Mexico, 1992-1997. The Journal of Infectious Diseases. 181: 779-82. PMID 10669376 DOI: 10.1086/315272 |
0.368 |
|
| 2000 |
Long K, Vasquez-Garibay E, Mathewson J, de la Cabada J, DuPont H. The impact of infant feeding patterns on infection and diarrheal disease due to enterotoxigenic Escherichia coli. Salud Publica De Mexico. 41: 263-70. PMID 10624137 DOI: 10.1590/S0036-36341999000400003 |
0.328 |
|
| 1999 |
Okhuysen PC, Chappell CL, Crabb JH, Sterling CR, DuPont HL. Virulence of three distinct Cryptosporidium parvum isolates for healthy adults. The Journal of Infectious Diseases. 180: 1275-81. PMID 10479158 DOI: 10.1086/315033 |
0.309 |
|
| 1999 |
Glandt M, Adachi JA, Mathewson JJ, Jiang ZD, DiCesare D, Ashley D, Ericsson CD, DuPont HL. Enteroaggregative Escherichia coli as a cause of traveler's diarrhea: Clinical response to ciprofloxacin Clinical Infectious Diseases. 29: 335-338. PMID 10476738 DOI: 10.1086/520211 |
0.371 |
|
| 1999 |
Caeiro JP, DuPont HL, Albrecht H, Ericsson CD. Oral rehydration therapy plus loperamide versus loperamide alone in the treatment of traveler's diarrhea. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 28: 1286-9. PMID 10451167 DOI: 10.1086/514786 |
0.304 |
|
| 1999 |
Chappell CL, Okhuysen PC, Sterling CR, Wang C, Jakubowski W, Dupont HL. Infectivity of Cryptosporidium parvum in healthy adults with pre-existing anti-C. parvum serum immunoglobulin G. The American Journal of Tropical Medicine and Hygiene. 60: 157-64. PMID 9988341 DOI: 10.4269/Ajtmh.1999.60.157 |
0.322 |
|
| 1998 |
DuPont HL, Ericsson CD, Mathewson JJ, Palazzini E, DuPont MW, Jiang ZD, Mosavi A, De La Cabada FJ. Rifaximin: A nonabsorbed antimicrobial in the therapy of travelers' diarrhea Digestion. 59: 708-714. PMID 9813398 DOI: 10.1159/000007580 |
0.33 |
|
| 1998 |
Caeiro JP, DuPont HL. Management of travellers' diarrhoea Drugs. 56: 73-81. PMID 9664200 DOI: 10.2165/00003495-199856010-00007 |
0.347 |
|
| 1998 |
Okhuysen PC, Chappell CL, Crabb J, Valdez LM, Douglass ET, DuPont HL. Prophylactic effect of bovine anti-Cryptosporidium hyperimmune colostrum immunoglobulin in healthy volunteers challenged with Cryptosporidium parvum. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 26: 1324-9. PMID 9636857 DOI: 10.1086/516374 |
0.309 |
|
| 1998 |
Okhuysen PC, Chappell CL, Sterling CR, Jakubowski W, DuPont HL. Susceptibility and serologic response of healthy adults to reinfection with Cryptosporidium parvum. Infection and Immunity. 66: 441-3. PMID 9453592 DOI: 10.1128/Iai.66.2.441-443.1998 |
0.316 |
|
| 1997 |
Ericsson CD, DuPont HL, Mathewson JJ. Single dose ofloxacin plus loperamide compared with single dose or three days of ofloxacin in the treatment of traveler's diarrhea Journal of Travel Medicine. 4: 3-7. PMID 9815469 DOI: 10.1111/J.1708-8305.1997.Tb00765.X |
0.31 |
|
| 1996 |
Lanjewar DN, Anand BS, Genta R, Maheshwari MB, Ansari MA, Hira SK, DuPont HL. Major differences in the spectrum of gastrointestinal infections associated with AIDS in India versus the West: An autopsy study Clinical Infectious Diseases. 23: 482-485. PMID 8879769 DOI: 10.1093/Clinids/23.3.482 |
0.359 |
|
| 1996 |
DuPont HL, Capsuto EG. Persistent diarrhea in travelers Clinical Infectious Diseases. 22: 124-128. PMID 8824975 DOI: 10.1093/Clinids/22.1.124 |
0.344 |
|
| 1996 |
Chappell CL, Okhuysen PC, Sterling CR, DuPont HL. Cryptosporidium parvum: intensity of infection and oocyst excretion patterns in healthy volunteers. The Journal of Infectious Diseases. 173: 232-6. PMID 8537664 DOI: 10.1093/Infdis/173.1.232 |
0.339 |
|
| 1996 |
DuPont HL. Overview of clinical experience of pefloxacin in gastrointestinal infections Clinical Drug Investigation. 11: 25-29. DOI: 10.2165/00044011-199600112-00006 |
0.384 |
|
| 1995 |
DuPont HL, Chappell CL, Sterling CR, Okhuysen PC, Rose JB, Jakubowski W. The infectivity of Cryptosporidium parvum in healthy volunteers. The New England Journal of Medicine. 332: 855-9. PMID 7870140 DOI: 10.1056/Nejm199503303321304 |
0.329 |
|
| 1995 |
Dupont HL. Pathogenesis of traveler's diarrhea Chemotherapy. 41: 33-39. PMID 7671645 DOI: 10.1159/000239395 |
0.335 |
|
| 1995 |
Gomez HF, Mathewson JJ, Johnson PC, DuPont HL. Intestinal immune response of volunteers ingesting a strain of enteroadherent (HEp-2 cell-adherent) Escherichia coli. Clinical and Diagnostic Laboratory Immunology. 2: 10-13. DOI: 10.1128/Cdli.2.1.10-13.1995 |
0.333 |
|
| 1994 |
DuPont HL. Prevention and Treatment Strategies in Giardiasis and Amoebiasis Drug Investigation. 8: 19-25. DOI: 10.1007/Bf03260001 |
0.352 |
|
| 1993 |
Ericsson CD, DuPont HL. Travelers’ diarrhea: Approaches to prevention and treatment Clinical Infectious Diseases. 16: 616-626. PMID 8507751 DOI: 10.1093/Clind/16.5.616 |
0.343 |
|
| 1993 |
DuPont HL, Ericsson CD, Mathewson JJ, Marani S, Knellwolf-Cousin AL, Martinez-Sandoval FG. Zaldaride maleate, an intestinal calmodulin inhibitor, in the therapy of travelers' diarrhea. Gastroenterology. 104: 709-15. PMID 8440431 DOI: 10.1016/0016-5085(93)91005-3 |
0.327 |
|
| 1993 |
DuPont HL. Antimicrobial therapy and prophylaxis Transactions of the Royal Society of Tropical Medicine and Hygiene. 87: 31-34. PMID 8108847 DOI: 10.1016/0035-9203(93)90534-W |
0.356 |
|
| 1993 |
DuPont HL. Travellers’ Diarrhoea: Which Antimicrobial? Drugs. 45: 910-917. PMID 7691498 DOI: 10.2165/00003495-199345060-00004 |
0.356 |
|
| 1993 |
DuPont HL. Quinolones in Salmonella typhi Infection Drugs. 45: 119-124. PMID 7689442 DOI: 10.2165/00003495-199300453-00020 |
0.374 |
|
| 1993 |
Murray DM, DuPont HL, Cooperstock M, Corrado ML, Fekety R. Evaluation of new anti-infective drugs for the treatment of gastritis and peptic ulcer disease associated with infection by Helicobacter pylori. Infectious Diseases Society of America and the Food and Drug Administration. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. S268-73. PMID 1477242 DOI: 10.1093/Clind/15.Supplement_1.S268 |
0.344 |
|
| 1993 |
Fekety R, DuPont HL, Cooperstock M, Corrado ML, Murray DM. Evaluation of new anti-infective drugs for the treatment of antibiotic-associated colitis. Infectious Diseases Society of America and the Food and Drug Administration. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. S263-7. PMID 1477241 DOI: 10.1093/Clind/15.Supplement_1.S263 |
0.348 |
|
| 1993 |
Corrado ML, DuPont HL, Cooperstock M, Fekety R, Murray DM. Evaluation of new anti-infective drugs for the treatment of chronic carriage of Salmonella. Infectious Diseases Society of America and the Food and Drug Administration. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. S259-62. PMID 1477240 DOI: 10.1093/Clind/15.Supplement_1.S259 |
0.352 |
|
| 1993 |
Cooperstock M, DuPont HL, Corrado ML, Fekety R, Murray DM. Evaluation of new anti-infective drugs for the treatment of diarrhea caused by Entamoeba histolytica. Infectious Diseases Society of America and the Food and Drug Administration. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. S254-8. PMID 1477239 DOI: 10.1093/Clind/15.Supplement_1.S254 |
0.349 |
|
| 1993 |
Cooperstock M, DuPont HL, Corrado ML, Fekety R, Murray DM. Evaluation of new anti-infective drugs for the treatment of diarrhea caused by Cryptosporidium. Infectious Diseases Society of America and the Food and Drug Administration. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. S249-53. PMID 1477238 DOI: 10.1093/Clind/15.Supplement_1.S249 |
0.349 |
|
| 1993 |
Cooperstock M, DuPont HL, Corrado ML, Fekety R, Murray DM. Evaluation of new anti-infective drugs for the treatment of diarrhea caused by Giardia lamblia. Infectious Diseases Society of America and the Food and Drug Administration. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. S244-8. PMID 1477237 DOI: 10.1093/Clind/15.Supplement_1.S244 |
0.345 |
|
| 1993 |
Corrado ML, DuPont HL, Cooperstock M, Fekety R, Murray DM. Evaluation of new anti-infective drugs for the treatment of cholera. Infectious Diseases Society of America and the Food and Drug Administration. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. S241-3. PMID 1477236 DOI: 10.1093/Clind/15.Supplement_1.S241 |
0.359 |
|
| 1993 |
Corrado ML, DuPont HL, Cooperstock M, Fekety R, Murray DM. Evaluation of new anti-infective drugs for the treatment of typhoid fever. Infectious Diseases Society of America and the Food and Drug Administration. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. S236-40. PMID 1477235 DOI: 10.1093/Clind/15.Supplement_1.S236 |
0.365 |
|
| 1993 |
DuPont HL, Cooperstock M, Corrado ML, Fekety R, Murray DM. Evaluation of new anti-infective drugs for the treatment of acute infectious diarrhea. Infectious Diseases Society of America and the Food and Drug Administration. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. S228-35. PMID 1477234 DOI: 10.1093/Clind/15.Supplement_1.S228 |
0.383 |
|
| 1992 |
Bandres JC, Mathewson JJ, Ericsson CD, Dupont HL. Trimethoprim/sulfamethoxazole remains active against enterotoxigenic Escherichia coli and Shigella species in Guadalajara, Mexico. The American Journal of the Medical Sciences. 303: 289-91. PMID 1580315 DOI: 10.1097/00000441-199205000-00003 |
0.341 |
|
| 1992 |
DuPont HL, Ericsson CD, Mathewson JJ, de la Cabada FJ, Conrad DA. Oral aztreonam, a poorly absorbed yet effective therapy for bacterial diarrhea in US travelers to Mexico. Jama. 267: 1932-5. PMID 1548825 DOI: 10.1001/Jama.1992.03480140058033 |
0.318 |
|
| 1992 |
Dupont HL. How Safe Is the Food We Eat? Jama: the Journal of the American Medical Association. 268: 3240. PMID 1433766 DOI: 10.1001/Jama.1992.03490220084033 |
0.308 |
|
| 1992 |
De la Cabada FJ, DuPont HL, Gyr K, Mathewson JJ. Antimicrobial therapy of bacterial diarrhea in adult residents of Mexico - Lack of an effect Digestion. 53: 134-141. PMID 1291401 DOI: 10.1159/000200988 |
0.333 |
|
| 1991 |
Jiang ZD, Nelson AC, Mathewson JJ, Ericsson CD, DuPont HL. Intestinal secretory immune response to infection with Aeromonas species and Plesiomonas shigelloides among students from the United States in Mexico. The Journal of Infectious Diseases. 164: 979-82. PMID 1940478 DOI: 10.1093/Infdis/164.5.979 |
0.351 |
|
| 1991 |
DuPont HL. Use of quinolones in the treatment of gastrointestinal infections European Journal of Clinical Microbiology &Amp; Infectious Diseases. 10: 325-329. PMID 1864292 DOI: 10.1007/Bf01967006 |
0.392 |
|
| 1991 |
DuPont HL. Nosocomial salmonellosis and shigellosis Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America. 12: 707-709. PMID 1813576 DOI: 10.1086/646277 |
0.346 |
|
| 1990 |
DuPont HL, Ericsson CD, DuPont MW, Cruz Luna A, Mathewson JJ. A randomized, open-label comparison of nonprescription loperamide and attapulgite in the symptomatic treatment of acute diarrhea. The American Journal of Medicine. 88: 20S-23S. PMID 2192554 DOI: 10.1016/0002-9343(90)90271-E |
0.311 |
|
| 1990 |
Vial PA, Mathewson JJ, DuPont HL, Guers L, Levine MM. Comparison of two assay methods for patterns of adherence to HEp-2 cells of Escherichia coli from patients with diarrhea. Journal of Clinical Microbiology. 28: 882-5. PMID 2191011 DOI: 10.1128/Jcm.28.5.882-885.1990 |
0.315 |
|
| 1990 |
Murray BE, Mathewson JJ, DuPont HL, Ericsson CD, Reves RR. Emergence of resistant fecal Escherichia coli in travelers not taking prophylactic antimicrobial agents. Antimicrobial Agents and Chemotherapy. 34: 515-8. PMID 2188583 DOI: 10.1128/Aac.34.4.515 |
0.325 |
|
| 1989 |
Reves RR, Hossain MM, Midthun K, Kapikian AZ, Naguib T, Zaki AM, DuPont HL. An observational study of naturally acquired immunity to rotaviral diarrhea in a cohort of 363 Egyptian children. Calculation of risk for second episodes using age-specific person-years of observation. American Journal of Epidemiology. 130: 981-8. PMID 2816905 DOI: 10.1093/Oxfordjournals.Aje.A115431 |
0.307 |
|
| 1989 |
DuPont HL. Progress in therapy for infectious diarrhea Scandinavian Journal of Gastroenterology, Supplement. 169: 1-3. PMID 2617178 DOI: 10.3109/00365528909091324 |
0.311 |
|
| 1988 |
Sullivan PS, Dupont HL, Arafat RR, Thornton SA, Selwyn BJ, Alamy MAE, Zakl AM. Illness and reservoirs associated with Giardia lamblia infection in rural Egypt: The case against treatment in developing world environments of high endemicity American Journal of Epidemiology. 127: 1272-1281. PMID 3369424 DOI: 10.1093/Oxfordjournals.Aje.A114919 |
0.347 |
|
| 1988 |
Ericsson CD, DuPont HL, Mathewson JJ, Johnson PC, De la Cabada FJ, Bitsura JAM. Test-of-cure stool cultures for traveler's diarrhea Journal of Clinical Microbiology. 26: 1047-1049. PMID 3290233 DOI: 10.1128/Jcm.26.5.1047-1049.1988 |
0.303 |
|
| 1987 |
Johnson PC, Ericsson CD, Morgan DR, Dupont HL, Cabada FJ. Lack of emergence of resistant fecal flora during successful prophylaxis of traveler's diarrhea with norfloxacin. Antimicrobial Agents and Chemotherapy. 30: 671-4. PMID 3800342 DOI: 10.1128/Aac.30.5.671 |
0.323 |
|
| 1987 |
Ericsson CD, Johnson PC, Dupont HL, Morgan DR, Bitsura JA, de la Cabada FJ. Ciprofloxacin or trimethoprim-sulfamethoxazole as initial therapy for travelers' diarrhea. A placebo-controlled, randomized trial Annals of Internal Medicine. 106: 216-220. PMID 3541724 DOI: 10.7326/0003-4819-106-2-216 |
0.341 |
|
| 1987 |
DuPont HL, Steele JH. The human health implication of the use of antimicrobial agents in animal feeds Veterinary Quarterly. 9: 309-320. PMID 3321681 DOI: 10.1080/01652176.1987.9694119 |
0.303 |
|
| 1987 |
DuPont HL. Bismuth subsalicylate in the treatment and prevention of diarrheal disease Drug Intelligence and Clinical Pharmacy. 21: 687-693. PMID 3308391 DOI: 10.1177/106002808702100901 |
0.33 |
|
| 1987 |
Ericsson CD, Patterson TF, Dupont HL. Clinical presentation as a guide to therapy for travelers' diarrhea. The American Journal of the Medical Sciences. 294: 91-6. PMID 3307410 DOI: 10.1097/00000441-198708000-00006 |
0.334 |
|
| 1987 |
Dupont HL, Corrado ML, Sabbaj J. Use of norfloxacin in the treatment of acute diarrheal disease The American Journal of Medicine. 82: 79-83. PMID 3300316 DOI: 10.1016/0002-9343(87)90624-3 |
0.308 |
|
| 1987 |
DuPont HL, Steele JH. Use of antimicrobial agents in animal feeds: implications for human health Reviews of Infectious Diseases. 9: 447-460. PMID 3299634 DOI: 10.1093/Clinids/9.3.447 |
0.311 |
|
| 1987 |
Oberhelman RA, de la Cabada FJ, Vasquez Garibay E, Bitsura JAM, DuPont HL. Efficacy of trimethoprim-sulfamethoxazole in treatment of acute diarrhea in a Mexican pediatric population The Journal of Pediatrics. 110: 960-965. PMID 3295163 DOI: 10.1016/S0022-3476(87)80425-0 |
0.392 |
|
| 1987 |
Mathewson JJ, Oberhelman RA, Dupont HL, Javier de la Cabada F, Garibay EV. Enteroadherent Escherichia coli as a cause of diarrhea among children in Mexico. Journal of Clinical Microbiology. 25: 1917-1919. DOI: 10.1128/Jcm.25.10.1917-1919.1987 |
0.329 |
|
| 1986 |
Ericsson CD, Johnson PC, DuPont HL, Morgan DR. Role of a novel antidiarrheal agent, BW942C, alone or in combination with trimethoprim-sulfamethoxazole in the treatment of traveler's diarrhea. Antimicrobial Agents and Chemotherapy. 29: 1040-6. PMID 3524436 DOI: 10.1128/Aac.29.6.1040 |
0.32 |
|
| 1986 |
Ericsson CD, DuPont HL, Johnson PC. Nonantibiotic therapy for travelers' diarrhea. Reviews of Infectious Diseases. S202-6. PMID 3523716 DOI: 10.1093/Clinids/8.Supplement_2.S202 |
0.318 |
|
| 1986 |
DuPont HL, Ericsson CD, Johnson PC, Cabada FJ. Antimicrobial agents in the prevention of travelers' diarrhea. Reviews of Infectious Diseases. S167-71. PMID 3523713 DOI: 10.1093/Clinids/8.Supplement_2.S167 |
0.326 |
|
| 1986 |
Zaki AM, DuPont HL, el Alamy MA, Arafat RR, Amin K, Awad MM, Bassiouni L, Imam IZ, el Malih GS, el Marsafie A. The detection of enteropathogens in acute diarrhea in a family cohort population in rural Egypt. The American Journal of Tropical Medicine and Hygiene. 35: 1013-22. PMID 2876656 DOI: 10.4269/Ajtmh.1986.35.1013 |
0.358 |
|
| 1985 |
DuPont HL. Cryptosporidiosis and the healthy host New England Journal of Medicine. 312: 1319-1320. PMID 3990729 DOI: 10.1056/Nejm198505163122009 |
0.346 |
|
| 1985 |
DuPont HL, Ericsson CD, Johnson PC. Chemotherapy and chemoprophylaxis of travelers' diarrhea. Annals of Internal Medicine. 102: 260-1. PMID 3966763 DOI: 10.7326/0003-4819-102-2-260 |
0.306 |
|
| 1985 |
Ericsson CD, DuPont HL, Galindo E, Mathewson JJ, Morgan DR, Wood LV, Mendiola J. Efficacy of bicozamycin in preventing traveler's diarrhea. Gastroenterology. 88: 473-7. PMID 3965336 DOI: 10.1016/0016-5085(85)90509-8 |
0.332 |
|
| 1985 |
Mathewson JJ, Johnson PC, DuPont HL, Morgan DR, Thornton SA, Wood LV, Ericsson CD. A newly recognized cause of travelers' diarrhea: enteroadherent Escherichia coli. The Journal of Infectious Diseases. 151: 471-5. PMID 3882849 DOI: 10.1093/Infdis/151.3.471 |
0.375 |
|
| 1985 |
Morgan DR, Sellin J, Gutierrez L, DuPont HL, Wood LV. Evaluation of BW942C, a novel antidiarrheal agent, against enterotoxins of Escherichia coli and Vibrio cholerae. Infection and Immunity. 48: 754-758. DOI: 10.1128/Iai.48.3.754-758.1985 |
0.31 |
|
| 1984 |
DuPont HL, Ericsson CD, Galindo E, Wood LV, Morgan D, Bitsura JA, Mendiola JG. Furazolidone versus ampicillin in the treatment of traveler's diarrhea. Antimicrobial Agents and Chemotherapy. 26: 160-3. PMID 6385838 DOI: 10.1128/Aac.26.2.160 |
0.308 |
|
| 1984 |
Cleary TG, Mathewson J, Pickering LK, Johnson P, Wood L, Morgan D, Ericsson CD, Dupont HL. DIARRHEA ASSOCIATED WITH E|[period]| COLI PRODUCING SHIGALIKE CYTOTOXIN Pediatric Research. 18. DOI: 10.1203/00006450-198404001-01070 |
0.31 |
|
| 1984 |
Morgan D, Johnson P, West A, Wood L, Ericsson C, Dupont H. Isolation of enteric pathogens from patients with travelers' diarrhea using fecal transport media Fems Microbiology Letters. 23: 59-63. DOI: 10.1111/J.1574-6968.1984.Tb01036.X |
0.303 |
|
| 1983 |
Harford PS, Murray BE, DuPont HL, Ericsson CD. Bacteriological studies of the enteric flora of patients treated with bicozamycin (CGP 3543/E) for acute nonparasitic diarrhea. Antimicrobial Agents and Chemotherapy. 23: 630-3. PMID 6859842 DOI: 10.1128/Aac.23.4.630 |
0.322 |
|
| 1983 |
Kim K, DuPont HL, Pickering LK. Outbreaks of diarrhea associated with Clostridium difficile and its toxin in day-care centers: Evidence of person-to-person spread The Journal of Pediatrics. 102: 376-382. PMID 6827409 DOI: 10.1016/S0022-3476(83)80652-0 |
0.318 |
|
| 1983 |
Carlson JR, Thornton SA, DuPont HL, West AH, Mathewson JJ. Comparative in vitro activities of ten antimicrobial agents against bacterial enteropathogens. Antimicrobial Agents and Chemotherapy. 24: 509-13. PMID 6651278 DOI: 10.1128/Aac.24.4.509 |
0.322 |
|
| 1983 |
Ekanem EE, Dupont HL, Pickering LK, Selwyn BJ, Hawkins CM. Transmission dynamics of enteric bacteria in day-care centers American Journal of Epidemiology. 118: 562-572. PMID 6637983 DOI: 10.1093/Oxfordjournals.Aje.A113661 |
0.313 |
|
| 1983 |
Wood LV, Morgan DR, DuPont HL. Antimicrobial resistance of gram-negative bacteria isolated from foods in Mexico Journal of Infectious Diseases. 148: 766. PMID 6631067 DOI: 10.1093/Infdis/148.4.766 |
0.302 |
|
| 1983 |
D'Eramo JE, DuPont HL, Preston GA, Smolensky MH, Roht LH. The short- and long-term effects of a handbook on antimicrobial prescribing patterns of hospital physicians. Infection Control : Ic. 4: 209-14. PMID 6554245 DOI: 10.1017/S0195941700058240 |
0.31 |
|
| 1983 |
Reves R, Bass P, DuPont HL, Sullivan P, Mendiola J. Failure to demonstrate effectiveness of an anticholinergic drug in the symptomatic treatment of acute travelers' diarrhea. Journal of Clinical Gastroenterology. 5: 223-7. PMID 6345649 DOI: 10.1097/00004836-198306000-00006 |
0.312 |
|
| 1983 |
Satterwhite TK, DuPont HL. Infectious diarrhea in office practice Medical Clinics of North America. 67: 203-220. PMID 6338309 DOI: 10.1016/S0025-7125(16)31232-9 |
0.331 |
|
| 1983 |
Ericsson CD, DuPont HL, Sullivan P, Galindo E, Evans DG, Evans DJ. Bicozamycin, a poorly absorbable antibiotic, effectively treats travelers' diarrhea. Annals of Internal Medicine. 98: 20-5. PMID 6336641 DOI: 10.7326/0003-4819-98-1-20 |
0.393 |
|
| 1983 |
Ericsson CD, DuPont HL. Cryptosporidium and diarrhea Lancet. 2: 914. PMID 6137725 DOI: 10.1016/S0140-6736(83)90899-1 |
0.333 |
|
| 1983 |
DuPont HL, Pickering LK. Acute enteric infections in Children: New prospects for treatment and prevention Gastroenterology. 84: 1068. DOI: 10.1016/0016-5085(83)90223-8 |
0.318 |
|
| 1982 |
DuPont HL, Evans DG, Rios N, Cabada FJ, Evans DJ, DuPont MW. Prevention of travelers' diarrhea with trimethoprim-sulfamethoxazole. Reviews of Infectious Diseases. 4: 533-9. PMID 7051246 DOI: 10.1093/Clinids/4.2.533 |
0.309 |
|
| 1982 |
DuPont HL, Reves RR, Galindo E, Sullivan PS, Wood LV, Mendiola JG. Treatment of travelers' diarrhea with trimethoprim/sulfamethoxazole and with trimethoprim alone. The New England Journal of Medicine. 307: 841-4. PMID 7050714 DOI: 10.1056/Nejm198209303071401 |
0.323 |
|
| 1982 |
Murray BE, Rensimer ER, DuPont HL. Emergence of high-level trimethoprim resistance in fecal Escherichia coli during oral administration of trimethoprim or trimethoprim--sulfamethoxazole. The New England Journal of Medicine. 306: 130-5. PMID 7033781 DOI: 10.1016/S0022-5347(17)52829-3 |
0.32 |
|
| 1981 |
Boyce JM, Landry M, Deetz TR, DuPont HL. Epidemiologic studies of an outbreak of nosocomial methicillin-resistant Staphylococcus aureus infections. Infection Control : Ic. 2: 110-6. PMID 6912204 DOI: 10.1017/S0195941700053881 |
0.354 |
|
| 1981 |
Pickering LK, Evans DG, DuPont HL, Vollet JJ, Evans DJ. Diarrhea caused by Shigella, rotavirus, and Giardia in day-care centers: prospective study. The Journal of Pediatrics. 99: 51-6. PMID 6265616 DOI: 10.1016/S0022-3476(81)80956-0 |
0.306 |
|
| 1979 |
Deetz TR, Evans DJ, Evans DG, DuPont HL. Serologic responses to somatic O and colonization-factor antigens of enterotoxigenic Escherichia coli in travelers. The Journal of Infectious Diseases. 140: 114-8. PMID 379245 DOI: 10.1093/Infdis/140.1.114 |
0.303 |
|
| 1979 |
Echeverria P, Blacklow NR, Zipkin C, Vollet JJ, Olson JA, DuPont HL, Cross JH. Etiology of gastroenteritis among Americans living in the Philippines. American Journal of Epidemiology. 109: 493-501. PMID 375723 DOI: 10.1093/Oxfordjournals.Aje.A112706 |
0.342 |
|
| 1979 |
DuPont HL. Escherichia coli diarrhea Clinical Microbiology Newsletter. 1: 1-3. DOI: 10.1016/S0196-4399(79)80032-X |
0.329 |
|
| 1978 |
DuPont HL. Etiologic diagnosis of acute diarrhea Annals of Internal Medicine. 88: 707-708. PMID 646266 DOI: 10.7326/0003-4819-88-5-707 |
0.302 |
|
| 1978 |
Echeverria P, Blacklow NR, Vollet JL, Ulyangco CV, Cukor G, Soriano VB, DuPont HL, Cross JH, Ørskov F, Ørskov I. Reovirus-Like Agent and Enterotoxigenic Escherichia coli Infections in Pediatric Diarrhea in the Philippines The Journal of Infectious Diseases. 138: 326-332. PMID 359725 DOI: 10.1093/Infdis/138.3.326 |
0.343 |
|
| 1978 |
Pickering LK, Dupont HL, Olarte J. Single-Dose Tetracycline Therapy for Shigellosis in Adults Jama: the Journal of the American Medical Association. 239: 853-854. PMID 342737 DOI: 10.1001/Jama.1978.03280360049018 |
0.314 |
|
| 1978 |
Dupont HL, West H, Evans DG, Olarte J, Evans DJ. Antimicrobial susceptibility of enterotoxigenic Escherichia coli. The Journal of Antimicrobial Chemotherapy. 4: 100-2. PMID 342481 DOI: 10.1093/Jac/4.1.100 |
0.323 |
|
| 1978 |
DuPont HL. Enteropathogenic organisms. New etiologic agents and concepts of disease Medical Clinics of North America. 62: 945-960. PMID 215856 DOI: 10.1016/S0025-7125(16)31748-5 |
0.317 |
|
| 1978 |
Pickering LK, Evans DJ, Muñoz O, DuPont HL, Coello-Ramírez P, Vollet JJ, Conklin RH, Olarte J, Kohl S. Prospective study of enteropathogens in children with diarrhea in Houston and Mexico. The Journal of Pediatrics. 93: 383-8. PMID 211215 DOI: 10.1016/S0022-3476(78)81142-1 |
0.34 |
|
| 1978 |
Evans DG, Satterwhite TK, Evans DJ, DuPont HL. Differences in serological responses and excretion patterns of volunteers challenged with enterotoxigenic Escherichia coli with and without the colonization factor antigen. Infection and Immunity. 19: 883-888. DOI: 10.1128/Iai.19.3.883-888.1978 |
0.304 |
|
| 1978 |
Evans DG, Evans DJ, Tjoa WS, DuPont HL. Detection and characterization of colonization factor of enterotoxigenic Escherichia coli isolated from adults with diarrhea. Infection and Immunity. 19: 727-736. DOI: 10.1128/Iai.19.2.727-736.1978 |
0.331 |
|
| 1978 |
Echeverria P, Hodge FA, Blacklow NR, Vollet JL, Cukor G, Dupont HL, Cross JH. Travelers' Diarrhea Among United States Marines In South Korea American Journal of Epidemiology. 108: 68-73. DOI: 10.1093/Oxfordjournals.Aje.A112586 |
0.367 |
|
| 1977 |
Pickering LK, DuPont HL, Olarte J, Conklin R, Ericsson C. Fecal leukocytes in enteric infections. American Journal of Clinical Pathology. 68: 562-5. PMID 920652 DOI: 10.1093/Ajcp/68.5.562 |
0.365 |
|
| 1977 |
Evans DG, Evans DJ, DuPont HL. Virulence factors of enterotoxigenic Escherichia coli. The Journal of Infectious Diseases. S118-23. PMID 330772 DOI: 10.1093/Infdis/136.Supplement.S118 |
0.31 |
|
| 1977 |
Echeverria P, Ho MT, Blacklow NR, Quinnan G, Portnoy B, Olson JG, Conklin R, DuPont HL, Cross JH. Relative importance of viruses and bacteria in the etiology of pediatric diarrhea in Taiwan. The Journal of Infectious Diseases. 136: 383-90. PMID 198481 DOI: 10.1093/Infdis/136.3.383 |
0.363 |
|
| 1977 |
Evans DG, Olarte J, DuPont HL, Evans DJ, Galindo E, Portnoy BL, Conklin RH. Enteropathogens associated with pediatric diarrhea in Mexico City The Journal of Pediatrics. 91: 65-68. PMID 195030 DOI: 10.1016/S0022-3476(77)80446-0 |
0.345 |
|
| 1977 |
Pickering LK, Dupont HL, Satterwhite TK. Evaluation of spectinomycin and gentamicin in the treatment of hospitalized patients with resistant urinary tract infections American Journal of the Medical Sciences. 274: 291-296. PMID 147625 DOI: 10.1097/00000441-197711000-00007 |
0.347 |
|
| 1977 |
Evans DJ, Ruiz-Palacios G, Evans DE, DuPont HL, Pickering LK, Olarte J. Humoral immune response to the heat-labile enterotoxin of Escherichia coli in naturally acquired diarrhea and antitoxin determination by passive immune hemolysis. Infection and Immunity. 16: 781-788. DOI: 10.1128/Iai.16.3.781-788.1977 |
0.306 |
|
| 1976 |
Goldschmidt MC, DuPont HL. Enteropathogenic escherichia coli: Lack of correlation of serotype with pathogenicity Journal of Infectious Diseases. 133: 153-156. PMID 1107438 DOI: 10.1093/Infdis/133.2.153 |
0.316 |
|
| 1975 |
Wannemacher RW, Pekarek RS, Klainer AS, Bartelloni PJ, Dupont HL, Hornick RB, Beisel WR. Detection of a leukocytic endogenous mediator-like mediator of serum amino acid and zinc depression during various infectious illnesses. Infection and Immunity. 11: 873-875. DOI: 10.1128/Iai.11.4.873-875.1975 |
0.316 |
|
| 1974 |
Snyder MJ, Perroni J, Gonzalez O, Palomino C, Gonzalez C, Music S, DuPont HL, Hornick RB, Woodward TE. Trimethoprim-sulfamethoxazole in the treatment of typhoid and paratyphoid fevers. The Journal of Infectious Diseases. 128: Suppl:734-7 p. PMID 4202211 DOI: 10.1093/Infdis/128.Supplement_3.S734 |
0.344 |
|
| 1973 |
Dupont HL, Hornick RB. Adverse Effect of Lomotil Therapy in Shigellosis Jama: the Journal of the American Medical Association. 226: 1525-1528. PMID 4587313 DOI: 10.1001/Jama.1973.03230130013006 |
0.303 |
|
| 1973 |
DuPont HL, Hornick RB, Dawkins AT, Heiner GG, Fabrikant IB, Wisseman CL, Woodward TE. Rocky Mountain spotted fever: a comparative study of the active immunity induced by inactivated and viable pathogenic Rickettsia rickettsii. The Journal of Infectious Diseases. 128: 340-4. PMID 4199563 DOI: 10.1093/Infdis/128.3.340 |
0.314 |
|
| 1972 |
DuPont HL, Hornick RB, Snyder MJ, Libonati JP, Formal SB, Gangarosa EJ. Immunity in shigellosis. II. Protection induced by oral live vaccine or primary infection. The Journal of Infectious Diseases. 125: 12-6. PMID 4550416 DOI: 10.1093/Infdis/125.1.12 |
0.305 |
|
| 1971 |
DuPont HL, Formal SB, Hornick RB, Snyder MJ, Libonati JP, Sheahan DG, LaBrec EH, Kalas JP. Pathogenesis of Escherichia coli diarrhea. The New England Journal of Medicine. 285: 1-9. PMID 4996788 DOI: 10.1056/Nejm197107012850101 |
0.311 |
|
| 1970 |
Clyde DF, Miller RM, DuPont HL, Hornick RB. Treatment of falciparum malaria caused by strain resistant to quinine. Jama. 213: 2041-5. PMID 4916651 DOI: 10.1001/Jama.1970.03170380015002 |
0.334 |
|
| Show low-probability matches. |